Cargando…

Immunohistochemistry cannot replace DNA analysis for evaluation of BRAF V600E mutations in papillary thyroid carcinoma

INTRODUCTION: The BRAF V600E mutation is the most common genetic event occurring in papillary thyroid cancer (PTC). Recently, the possibility of using immunohistochemistry (IHC) to detect the BRAF V600E mutation has been reported. MATERIALS AND METHODS: In 140 patients with classical PTC, the status...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szymonek, Monika, Kowalik, Artur, Kopczyński, Janusz, Gąsior-Perczak, Danuta, Pałyga, Iwona, Walczyk, Agnieszka, Gadawska-Juszczyk, Klaudia, Płusa, Agnieszka, Mężyk, Ryszard, Chrapek, Magdalena, Góźdź, Stanisław, Kowalska, Aldona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650387/ https://www.ncbi.nlm.nih.gov/pubmed/29088832 http://dx.doi.org/10.18632/oncotarget.20451

Ejemplares similares

Histopathology and immunohistochemistry as prognostic factors for poorly differentiated thyroid cancer in a series of Polish patients
por: Walczyk, Agnieszka, et al.
Publicado: (2020)

Immune Profiling of Medullary Thyroid Cancer—An Opportunity for Immunotherapy
por: Hińcza-Nowak, Kinga, et al.
Publicado: (2021)

CD276 as a Candidate Target for Immunotherapy in Medullary Thyroid Cancer
por: Hińcza-Nowak, Kinga, et al.
Publicado: (2023)

Does the TT Variant of the rs966423 Polymorphism in DIRC3 Affect the Stage and Clinical Course of Papillary Thyroid Cancer?
por: Hińcza, Kinga, et al.
Publicado: (2020)

Coexisting Germline CHEK2 and Somatic BRAF(V600E) Mutations in Papillary Thyroid Cancer and Their Association with Clinicopathological Features and Disease Course
por: Gąsior-Perczak, Danuta, et al.
Publicado: (2019)

The Delayed Risk Stratification System in the Risk of Differentiated Thyroid Cancer Recurrence
por: Kowalska, Aldona, et al.
Publicado: (2016)

Evaluation of molecular diagnostic approaches for the detection of BRAF p.V600E mutations in papillary thyroid cancer: Clinical implications
por: Kowalik, Artur, et al.
Publicado: (2017)

The impact of BMI on clinical progress, response to treatment, and disease course in patients with differentiated thyroid cancer
por: Gąsior-Perczak, Danuta, et al.
Publicado: (2018)

Delayed risk stratification system in pT1aN0/Nx DTC patients treated without radioactive iodine
por: Gąsior-Perczak, Danuta, et al.
Publicado: (2017)

The p.G534E variant of HABP2 is not associated with sporadic papillary thyroid carcinoma in a Polish population
por: Kowalik, Artur, et al.
Publicado: (2017)

Is Male Sex A Prognostic Factor in Papillary Thyroid Cancer?
por: Gajowiec, Aleksandra, et al.
Publicado: (2021)

Variation of the epidemiological structure of thyroid cancer between year 2000 and 2012
por: Kowalska, Aldona, et al.
Publicado: (2013)

The Cut-Off Level of Recombinant Human TSH-Stimulated Thyroglobulin in the Follow-Up of Patients with Differentiated Thyroid Cancer
por: Kowalska, Aldona, et al.
Publicado: (2015)

Diagnostic performance evaluation of post-operative serum calcitonin (CT) levels as a factor for good prognosis in medullary thyroid carcinoma (MTC)
por: Gąsior-Perczak, Danuta, et al.
Publicado: (2013)

Incidence of the CHEK2 Germline Mutation and Its Impact on Clinicopathological Features, Treatment Responses, and Disease Course in Patients with Papillary Thyroid Carcinoma
por: Gąsior-Perczak, Danuta, et al.
Publicado: (2021)

Are molecular tests necessary to diagnose NIFTP?
por: Kuchareczko, Artur, et al.
Publicado: (2021)

Papillary Thyroid Cancer in a Struma Ovarii in a 17-Year-Old Nulliparous Patient: A Case Report
por: Gonet, Agnieszka, et al.
Publicado: (2020)

Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a problematic entity
por: Zajkowska, Klaudia, et al.
Publicado: (2020)

Telomeres and telomerase in oncogenesis
por: Trybek, Tomasz, et al.
Publicado: (2020)

Snail-1 Overexpression Correlates with Metastatic Phenotype in BRAF(V600E) Positive Papillary Thyroid Carcinoma
por: Wieczorek-Szukala, Katarzyna, et al.
Publicado: (2020)

Effective Preoperative Plasmapheresis Treatment of Severe Hyperthyroidism in a Patient with Giant Toxic Nodular Goiter and Methimazole-Induced Agranulocytosis
por: Barwinek, Katarzyna, et al.
Publicado: (2020)

Late-Onset Medullary Thyroid Cancer in a Patient with a Germline RET Codon C634R Mutation
por: Walczyk, Agnieszka, et al.
Publicado: (2021)

Evaluation of ultrasound-guided fine needle aspiration biopsy (USG-FNAB) of thyroid nodules: 12 years of accepted diagnostic algorithm in Holycross Cancer Centre (HCC) in Kielce
por: Sygut, Jacek, et al.
Publicado: (2013)

Effectiveness analysis of papillary thyroid carcinoma (PTC) diagnostics in Holycross Cancer Centre (HCC) in Kielce according to fine needle aspiration biopsy quality assurance program in pathology department between years 2001 and 2012
por: Sygut, Jacek, et al.
Publicado: (2013)

Prevalence of macroprolactinaemia in regularly menstruating women with non-toxic goitre or autoimmune thyroid disease
por: Lewandowski, Krzysztof C, et al.
Publicado: (2012)

Repeated nondiagnostic result of thyroid fine-needle aspiration biopsy
por: Ziemiańska, Klaudia, et al.
Publicado: (2017)

Validation of Immunohistochemistry for the Detection of BRAF V600E-Mutated Lung Adenocarcinomas
por: Gow, Chien-Hung, et al.
Publicado: (2019)

Immunohistochemistry is highly sensitive and specific for detection of BRAF V600E mutation in pleomorphic xanthoastrocytoma
por: Ida, Cristiane M, et al.
Publicado: (2013)

BRAF‐V600E immunohistochemistry in a large series of glial and glial–neuronal tumors
por: Breton, Quentin, et al.
Publicado: (2017)

Clinical significance of immunohistochemistry to detect BRAF V600E mutant protein in thyroid tissues
por: Zhang, Yini, et al.
Publicado: (2021)

BRAF V600E Immunohistochemistry Predicts Prognosis of Patients with Cutaneous Melanoma in Thai population
por: Meevassana, Jiraroch, et al.
Publicado: (2022)

Comparison of Immunohistochemistry and Direct Sanger Sequencing for Detection of the BRAF(V600E) Mutation in Thyroid Neoplasm
por: Oh, Hye-Seon, et al.
Publicado: (2018)

Reflectance confocal microscopy features of BRAF V600E mutated thin melanomas detected by immunohistochemistry
por: Urvanegia, Ana Claudia, et al.
Publicado: (2017)

Immunogenicity And Safety Of The 13-Valent Pneumococcal Conjugate Vaccine In Patients With Monoclonal Gammopathy Of Undetermined Significance – Relationship With Selected Immune And Clinical Parameters
por: Pasiarski, Marcin, et al.
Publicado: (2019)

Utility of BRAF VE1 Immunohistochemistry as a Screening Tool for Colorectal Cancer Harboring BRAF V600E Mutation
por: Kwon, Jeong-Hwa, et al.
Publicado: (2018)

VE1 immunohistochemistry predicts BRAF V600E mutation status and clinical outcome in colorectal cancer
por: Schafroth, Christian, et al.
Publicado: (2015)

Is immunohistochemistry of BRAF V600E useful as a screening tool and during progression disease of melanoma patients?
por: Schirosi, Laura, et al.
Publicado: (2016)

Immunohistochemistry as an accurate tool for the assessment of BRAF V600E and TP53 mutations in primary and metastatic melanoma
por: Rusu, Stefan, et al.
Publicado: (2021)

The Influence of Red Meat on Colorectal Cancer Occurrence Is Dependent on the Genetic Polymorphisms of S-Glutathione Transferase Genes
por: Klusek, Justyna, et al.
Publicado: (2019)

Current Knowledge of Germline Genetic Risk Factors for the Development of Non-Medullary Thyroid Cancer
por: Hińcza, Kinga, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_velnfvl70jc5jihl2e4d1g1bsr